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1. Introduction 
Telomeres are essential for chromosome replication and genome integrity. The 3’ single-
stranded overhang of human telomere may adopt particular conformations such as T-loops 
and G-quadruplexes. Reactivated in most tumors, telomerase, a specific reverse 
transcriptase that elongates the telomeres, is thought to enable cancer cells to proliferate in 
an unlimited manner, thereby correcting the normal telomere erosion that occurs during cell 
division. The level of interest in G-quadruplex has increased due to their ability to inhibit 
telomerase activity. We have investigated chromosomal binding and the cellular effects 
induced by pyridine derivative G-quadruplex ligand in human normal and tumour cells. 
We show from our analysis that this G-quadruplex ligand preferentially binds the terminal 
regions of chromosomes in both normal and tumour cells. This compound also induces 
DNA damage signals in a strictly ATM-dependent manner, inhibits cell proliferation and 
induces apoptosis. We further observed by telo-FISH and Chromosome Orientation-FISH 
that this compound induces specific telomere aberrations either during or after replication 
and mainly consisting of sister telomere fusions and recombination events principally 
involving the lagging strand telomeres. We have also observed that ATM (Ataxia 
Telangiectasia Mutated) and ATR (Ataxia Telangiectasia Related) reduce telomere instability 
independently of apoptosis suggesting its direct role in preventing inappropriate DNA 
repair at the telomeres. We have further demonstrated that, even at elevated concentrations, 
G-quadruplex ligand has limited effects on proliferation of normal cells, and does not 
induce apoptosis or telomere aberrations. Interestingly, we observed induction of reversible 
premature senescence in primary fibroblasts. Taken together, our results suggest that the 
protein composition and/or organization of the telomeres differ markedly between normal 
and cancer cells, and provide higher telomere stability to normal cells. 
1.1 Structure of telomeres  
Telomeres are nucleoprotein structures located at the ends of chromosomes (Figure 1A). 
Human telomeric DNA contains double-stranded repeats of the motif TTAGGG (5 – 20 Kb) 
followed by a G-rich 3’-overhang (Makarov et al., 1997) (Figure 1B). In human 
chromosomes, the long terminal protrusions of single-stranded G-rich sequence have been 
reported to vary from 50 to more than 500 nucleotides (Makarov et al., 1997; Stewart et al., 
2003). Telomeres have also been considered to be transcriptionally silent, but mammalian 
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telomeres are transcribed into telomeric repeat-containing RNA (Azzalin et al., 2007; 
Schoeftner & Blasco, 2008; Ho et al., 2008) (Figure 1B).  
Telomeric DNA is capped by shelterin, a telomere-specific multiprotein complex (de Lange, 
2005). Three shelterin subunits, TRF1 (Telomeric Repeat Factor 1) (Zhong et al., 1992; 
Broccoli et al., 1997), TRF2 (Telomeric Repeat Factor 2) (Broccoli et al., 1997; Bilaud et al., 
1997) and POT1 (Protection Of Telomere 1) (Baumann & Cech, 2001; Loyza et al., 2004; 
Hockemeyer et al., 2005) directly recognize TTAGGG repeats and are interconnected by 
three additional shelterin proteins, TIN2 (TRF1 Interacting Nuclear Protein 1) (Kim et al., 
1999; O’Connor et al., 2006), TPP1 (TINT1-PIP1-PTOP1) (Hockmeyer et al., 2007; Ye et al., 
2004; O’Connor et al., 2006; Chen et al., 2007; Xin et al., 2007) and Rap1 (Repressor activator 
protein 1) (Li et al., 2000; Li & de Lange, 2003; O’Connor et al., 2006), forming a complex that 
allows cells to distinguish telomeres from sites of DNA damage. 
 
 
Fig. 1. Human telomeres evidenced by hybridization with a PNA-Cy3 (Peptide Nucleic  
Acid – Cyanine 3) probe on chromosome counterstained with DAPI (A) and schematic 
representation of shelterin on telomeric DNA in the presence of telomeric repeat-containing 
RNA (B). 
Telomeres can adopt a protective conformation, the T-loop structure, in which the telomeric 
3’-overhang is incorporated into the proximal double stranded telomeres (Griffith et al., 
1999) (Figure 2A). Junction-specific binding would also allow TRF2 to stabilize a strand 
invasion structure that is thought to exist at the strand invasion site of the T-loop (Stansel et 
al., 2001; Fouche et al., 2006). The T-loop has been proposed to prevent telomeres from being 
recognized as a DNA double strand breaks (DSBs) and thus from activating cell cycle 
checkpoints, inappropriate DNA repair and cell death (Smogrozewska & de Lange, 2004). 
Nevertheless, the DNA damage machinery recognizes functional telomeres during 
replication (Verdun et al., 2005). At the telomeres, a localized DNA damage response (DDR) 
seems to be required for processing and the formation of protective structures such as the T-
loop after replication.  
The guanine-rich sequences of telomeric DNA are susceptible to form in vitro G-quadruplex 
as a consequence of the propensity of guanine to associate with each other in a stable 
hydrogen-bonded arrangement, the G-quartet (Neidle & Parkinson, 2003) (Figure 2B and 
2C). G-quartet is stabilized by a monovalent cation (Na+ or K+) localized in the centre of the 
structure (Figure 2B) (Williamson et al., 1989; Sen & Gilbert, 1990). A three-dimensional 
arrangement of three G-quartets (Figure 2D) can result in a variety of G-quadruplex 
structures. The four-stranded quadruplex structural types depend on the number and the 
orientation of the DNA strands. Indeed, intramolecular G-quadruplexes comprise one DNA 
strand whereas dimeric and tetrameric intermolecular quadruplex involve 2 and 4 DNA 
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strands respectively. G-quadruplex heterogeneity also depends on the orientation of the 
DNA strands (parallel or anti-parallel) and the guanine conformation (syn or anti).  
 
 
Fig. 2. Structure of the telomere. Schematic representation of T-loop structure (A). Chemical 
structure of guanine (B), of a G-quartet (C) and depiction of a G-quadruplex (D). 
1.2 Telomerase 
The maintenance of telomeric repeats in most eukaryotic organisms requires telomerase, 
which consists of a reverse transcriptase and an RNA template that dictates the synthesis of 
the G-rich strand of telomere terminal repeats (Greider & Blackburn, 1987; Autexier & Lue, 
2006). The catalytic function of this enzyme depends minimally on two components: TERT 
(Telomerase Reverse Transcriptase) protein (Kilian et al., 1997) and telomerase RNA (TR: 
Telomerase RNA template) (Feng et al., 1995; Blasco et al., 1995). However, other proteins 
(dyskerin, Ku70, Ku80, nucleolin, hsp23, hsp90) have also been proposed to associate with 
human telomerase (Mitchell et al., 1999; Chai et al., 2002; Ting et al., 2005; Khurts et al., 2004; 
Forsyhthe et al., 2001; Cohen et al., 2007). By copying a short template sequences within its 
intrinsic RNA moiety, telomerase synthesizes the telomeric DNA strand running 5’ to 3’ 
toward the distal end of the chromosome, thereby extending it. Regulated extension of the 
chromosomal DNA termini occurs to compensate for the shortening that results from 
nuclease action and incomplete terminal DNA replication (Makarov et al., 1997; Blackburn, 
2005; de Lange, 2005). Telomerase gene expression is active only in germ cells and stem cells 
and is repressed in most somatic cells, although limited expression is found in normal 
cycling cells (Masutomi et al., 2003). The expression of telomerase is reactivated in most 
tumours and is thought to enable cancer cells to proliferate in an unlimited manner by 
maintaining and protecting telomeres. Telomerase has therefore become a target for the 
development of new cancer drugs. In addition to telomerase however, other mechanisms to 
maintain telomere length have been identified in human tumours. Indeed, telomere 
lengthening is achieved in some cancer cells by recombination events between telomeres, 
known as alternative lengthening of telomeres (ALT) (Muntoni & Reddel, 2005).  
1.3 Functions of telomeres  
1.3.1 Telomeres protect chromosome ends 
Telomeres are nucleoprotein structures essential for chromosome replication and genome 
integrity because they protect against instability-promoting events (degradation of the 
terminal regions of chromosomes, fusion of a telomere either with another telomere or with 
a broken DNA end, or inappropriate recombination) (Zakian, 1995). Telomeres allow cells to 
distinguish natural chromosome ends from damaged DNA by inhibiting the canonical DNA 
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damage response (NHEJ and HR). Telomerase, the T-loop and the shelterin complex serve 
to prevent telomeres from being recognized as DNA damage. Indeed, TRF2 can inhibit the 
ATM-dependent DNA damage response (Celli & de Lange, 2006; Karlseder et al., 2004; 
Denchi & de Lange, 2007, Bae & Baumann, 2007) whereas POT1 can inhibit inappropriate 
recombination at the telomeres (He 2006) and NHEJ (Denchi & de Lange, 2007). However, 
functional human telomeres are recognized by proteins involved in the DNA damage 
response, highlighting that a localized DNA damage response at the telomeres after 
replication is essential for recruiting the processing machinery that promotes formation of a 
chromosome end protection complex (Verdun et al., 2005). Without the protective activity of 
shelterin or when they shorten, telomeres are no longer hidden from the DNA damage 
surveillance and DNA repair pathways that may inappropriately process chromosome ends 
(Palm & de Lange, 2008).  
1.3.2 Telomere shortening and replicative senescence 
The replication of telomeres by conventional mechanisms is inevitably incomplete, leading 
to telomere shortening at each round of cell division (the end-replication problem) 
(Olovnikov, 1973). On the other hand, the processing reactions required to re-create a 3’ end 
also lead to telomere shortening after replication (Dionne & Wellinger, 1998). Telomerase, 
the unique enzyme in the cell that can add telomeric repeats de novo to the 3’ end, 
counteracts these losses. In humans, however the expression of the telomerase is highly 
regulated and most somatic cells do not possess any telomerase activity, and as a result 
telomere shortening is prevalent in proliferating cells. Because end-replication results in 
telomere shortening with each round of replication, the telomeres of human somatic cells act 
as a mitotic clock, shortening with age both in vitro and in vivo in a replication dependent 
manner (Olovnikov, 1973; Makarov et al., 1997). When telomeres reach a critical length 
(Hayflick & Moorhead, 1961), dysfunctional telomeres trigger a damage response leading to 
growth arrest (cellular senescence) or cell death (apoptosis) (Figure 3).  
Indeed, uncapping of one telomere, because of damage or loss of telomere sequences or 
because of destabilization of the protein complex, triggers a DNA damage response and an 
attempt by the cell to repair the unprotected extremity (Takai et al., 2003; d’Adda di Fagagna 
et al., 2003). Dysfunctional telomeres are sensed as double strand DNA breaks, activating 
the DNA damage response checkpoints, including ATM and ATR (Karlseder et al., 1999; 
d’Adda di Fagagna et al., 2003). Hence, dysfunctional telomeres became associated with 
DNA damage response factors such as γ-H2AX, 53BP1, Rad17 and Mre11 leading to the 
formation of TIFs (Telomere dysfunction-Induced Foci) in an ATM- and ATR-dependent 
manner (Takai et al., 2003; Konishi & de Lange, 2008) and to the induction of replicative 
senescence. Cellular senescence is a cell-cycle arrest event in which cells show characteristic 
morphological changes and stain positively for senescence-associated β-galactosidase (SA-β-
gal) activity (Hayflick & Moorhead, 1961; Dimri et al., 1995; Cosme-Blanco et al., 2007), and 
proceed through central signalling pathways leading to the activation of the p53 and 
retinoblastoma tumour suppressor proteins (pRb). Therefore, telomere shortening is 
considered to be the main causal mechanism underlying replicative senescence, but 
telomere deprotection, DNA damage, numerous stresses and/or signalling imbalance can 
also induce senescence (d’Adda di Fagagna et al., 2003; Cosme-Blanco et al., 2007). Other 
sources of telomere damage (exogenous events, such as UV irradiation, or endogenous 
factors, such as reactive oxygen species) may lead to sudden telomere shortening and 
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uncapping presumably with very similar consequences (von Zglinicki, 2000; Oikawa et al., 
2001). Owing to its anti-proliferative effects, cellular senescence triggered by telomere 
dysfunction and/or erosion is considered to be a strong protective mechanism against 
unlimited proliferation (Harley et al., 1991) and an efficient tumour suppressor mechanism 
(Sedivy, 2007; Feldser & Greider, 2007). 
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Fig. 3. Induction of replicative senescence and cellular immortalization. 
1.4 Replication of telomeres 
Bidirectional replication initiates at defined origins but telomeric chromatin that has the 
ability to form unusual structures might be a source of difficulties for the passage of the 
replication fork (Fouche et al., 2006). Leading strand replication occurs continuously 
whereas lagging strand replication is discontinuous and the DNA is synthesized via Okazaki 
fragments. Telomere replication occurs in two phases, S-phase and G2/M phase (Verdun & 
Karlseder, 2006 and 2007) which implicate specific mechanisms to initiate, control and 
coordinate the synthesis of leading and lagging strands at the telomeres and to allow G-tail 
formation and recapping of the telomeres after their replication.  
The telomere structure, T-loop, G-quadruplex and D-loop, cause fork progression problems 
(Fouche et al., 2006; Verdun & Karlseder, 2006). During the G1 phase, the T-loop structure 
prevents telomeres from being recognized as DSBs. During S-phase however, T-loop 
opening and/or difficulties during the passage of the replication fork induce a localized 
DNA damage response (Verdun et al., 2005) but do not engage the downstream elements of 
the cascade that would lead to cell cycle checkpoint enforcement. Naturally, stalling of the 
replication fork at the telomeres induces an ATM/ATR-dependent DNA damage response. 
Proteins involved in the DNA damage response such as MRE11/RAD50/NBS, RPA, 
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trimeric complex of Rad9/Rad1/Hus1 and β DNA polymerase are detected at telomeres at 
the end of S phase (Verdun et al., 2005; Verdun & Karlseder, 2006 and 2007; Jazayeri et al., 
2006; Gilson & Geli, 2007). RPA, POT1 and helicases from the RecQ family (BLM and WRN) 
regulated by TRF2 and POT1 could be implicated in the resolution of unusual DNA 
structure and G-quadruplexes on the G-rich strand (Crabbe et al., 2004; Shen & Loeb, 2001; 
Opresko et al., 2004 and 2005) to facilitate progression of the replication fork. ATM and 
MRE11 located at telomeres during G2/M phase suggest that ATM-dependent damage is 
required for generation of the 3’ overhang at the leading telomere (Verdun & Karlseder, 
2006) implicating Apollo through its 5’ resection activity (Lenain et al., 2006; van Overbeek 
& de Lange, 2006 ; Dimitrova & de Lange, 2009). Apollo, a member of the SNM1/PSO2 
family of nucleases, contributes to the repair of interstrand crosslink and the cleavage of 
hairpins during V(D)J recombination and is recruited to chromosome ends via interaction 
with TRF2 (Ye et al., 2010 ; Wu et al., 2010). Sfeir et al. have reported that 80% of the C-rich 
strands terminate in CCCAATC-5’ (Sfeir et al., 2005), suggesting the actions of a specific 
nuclease that is POT1-dependent. Indeed POT1 is implicated in the generation of the correct 
sequence at chromosome ends (Hockmeyer et al., 2005). ATM-dependent signalling at 
telomeres in G2 is required for T-loop re-formation (Verdun et al., 2005; Verdun & 
Karlseder, 2006). Proteins implicated in homologous recombination (RAD51, RAD52 and 
XRCC3) and telomeric proteins (TRF2, TRF1 and TIN2) are recruited at telomeres to 
facilitate T-loop formation after replication (Stansel et al., 2001; de Lange, 2005; Verdun et 
al., 2005; Verdun & Karlseder, 2006; Amiard et al., 2007, Fouche et al., 2006).  
1.5 Telomeres, telomerase and cancer 
1.5.1 Telomere stabilization  
When human cells bypass replicative senescence via the inactivation of p53 or Rb, they 
continue to divide in spite of very short telomeres leading to the deprotection of 
chromosome ends (Counter et al., 1994; Stewart & Weinberg, 2000; Kim et al., 2002; 
Londono-Vallejo, 2008). As the substrates of repair mechanisms, critically shortened 
telomeres are highly recombinogenic leading to the formation of dicentric chromosomes by 
NHEJ, anaphase bridges, engagement of the breakage-fusion-breakage (BFB) cycle 
(Murname, 2006; Bailey & Murname, 2006), and the generation of novel chromosomal 
variants that could lead to the emergence of a pro-cancer genome. Indeed, genomic 
instability driven by dysfunctional telomeres is associated with the transition from benign 
lesions to malignant cancer. Eventually, the number of unstable chromosomes being too 
high, cells cannot divide further without losing vital genetic material and thus they initiate 
mitotic catastrophe and die (crisis) (Figure 3). Consequently, crisis represents another 
powerful barrier to uncontrolled cell proliferation. To escape from death, cells that enter 
crisis must acquire a mechanism of telomere maintenance that is most often achieved by the 
re-expression of telomerase (Counter et al., 1992 and 1994) (Figure 3). In stabilizing telomere 
length, telomerase reactivation facilitates an indefinite replication potential, which is a 
hallmark of tumour cells. The reactivation of telomerase thus allows cells to stabilize their 
genome and divide indefinitely. Amplification of the hTERT locus and 
duplication/translocation of this locus has been linked to the reactivation of telomerase. In 
addition, the promoter of the hTERT gene is a target for numerous oncogenes (such as c-
myc) or tumour suppressors (e.g. p53). The telomerase ribonucleoprotein recognizes 
telomeric DNA during S phase (Jady et al., 2006; Tomlinson et al., 2006) and sequentially 
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adds telomeric repeats to the 3’ end. Telomerase then undergoes a translocation reaction to 
enable another round of nucleotide addition (Morin, 1989; Autexier & Lue, 2006; Hug & 
Lingner, 2006).  
Transformed cells may also acquire alternative mechanisms of telomere maintenance (ALT) 
based on homologous recombination between telomeres (Figure 3) (Bryan et al., 1997; 
Muntoni & Reddel, 2005; Stewart, 2005). ALT cells are characterized by high level of 
telomeric exchange (Londono-Vallejo et al., 2004; Bailey et al., 2004; Dunham et al., 2000), 
highly heterogeneous telomeres and ALT-associated PML bodies colocalized with telomeres 
(Muntoni & Reddel, 2005; Dunham et al., 2000).  
1.5.2 Telomere recombination and chromosomal instability 
Dysfunctional telomeres are sensed as double strand DNA breaks which activates the DNA 
damage response checkpoints, including the ATM and ATR pathways (Karlseder et al., 
1999; d’Adda di Fagagna et al., 2003). In human cells, the activation of ATM and ATR, 
members of the phosphatidylinositol 3-kinase-like kinase family, leads to the 
phosphorylation and activation of the central cell cycle regulator p53, CHK1 (checkpoint 
kinase 1) and CHK2 (checkpoint kinase 2), which in turn facilitates G1 and G2 arrest (Shiloh, 
2003; Khanna et al., 2001). ATM responds to DSBs (Shiloh, 2003) whereas ATR responds to 
lesions after they have been processed to single-stranded DNA intermediates (Zhou et al., 
2003). Two main pathways, HR (homologous recombination) or NHEJ (non-homologous 
end joining), can repair DNA damage. The HR pathway is a very accurate repair mechanism 
because sister chromatid serves as a template to guide repair of the broken strand during the 
S and G2 phases of the cell cycle. NHEJ, which is potentially less accurate because two 
termini of broken DNA are ligated, is the prevailing repair pathway during the G1 and M 
phases. 
The loss of telomere function can result in telomere fusion events in an NHEJ-dependent 
manner (Smogorzewska et al., 2002; Celli & de Lange, 2005) containing telomeric repeat 
DNA. Prior to replication, telomere fusion results from the linkage of the G-strand of one 
chromosome end to the C-strand of another chromosome (van Steensel et al., 1998; Bailey et 
al., 2001). These telomere fusions induce the formation of dicentric chromosome with 
telomere sequences at the fusion point and anaphase bridge. In contrast, after replication, 
telomere fusion can result from the linkage of two chromatids of different chromosomes 
resulting from C-strand synthesis with blunt ends or two sister chromatids leading to the 
propagation of the breakage/fusion/breakage (B/F/B) cycle (Fouladi et al., 2000). The 
B/F/B cycle is a well-established mechanism that causes genome instability leading to 
complex chromosomal rearrangements and cancer genome amplification. Indeed, deficiency 
of several proteins such as ATM, TRF2, POT1 and DNA-PKcs result in telomere fusion 
events that are dependent on factors involved in NHEJ (van Steensel et al., 1998; Veldman et 
al., 2004; Yang et al., 2005; Bailey et al., 2001; Bailey & Murnane, 2006; Gilley et al., 2001; 
Metcalfe et al., 1996). In addition, CO-FISH (Chromosome Orientation-Fluorescence In Situ 
Hybridization) analysis has shown the existence of telomere-DSB fusion (Crabbe et al., 2004; 
Bailey & Murnane, 2006). 
Homologous recombination has been observed at dysfunctional telomeres. Indeed, 
recombination can occur within the T-loop structure (T-loop HR or telomere rapid deletion) 
(Wang et al., 2004; de Lange & Petrini, 2000), between sister telomeres (Telomere Sister 
Chromatid Exchange or T-SCE) (Rudd et al., 2007; Baird, 2008; Bailey et al., 2004) and 
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between telomere and chromosome-internal telomeric sequences leading to the formation of 
TDM (Telomeric DNA-containing Double Minute Chromosomes) (Zhu et al., 2003, Palm & 
de Lange, 2008). 
Another source of telomere-driven instability is the modification of the telomere 
nucleoprotein complex. The best characterized of these modifications is the inactivation of 
TRF2 in cells, which leads to rampant uncapping and chromosome fusions in the presence 
of telomere repeats (van Steensel et al., 1998).  
1.6 Telomeric G-quadruplexes are new targets for cancer therapy  
Because telomerase is reactivated in most human tumours but not in normal human cells, it 
is regarded as a potential drug target. Several classes of telomerase inhibitors have now 
been developed and inhibit this enzyme through the targeting of its RNA (Asia et al., 2003; 
Herbert et al., 2005; Jackson et al., 2007; Gomez-Millan et al., 2007; Gryanov et al., 2007) or 
catalytic components (Ward & Autexier, 2005; El-Daly et al., 2005). However compounds 
that stabilize the telomeric G-quadruplex have been shown to inhibit the activity of 
telomerase and disrupt telomere capping and maintenance, making the human telomeric 
DNA G-quadruplex also an attractive target for cancer therapeutic intervention (Mergny & 
Helene, 1998; Riou et al., 2002; Gowan et al., 2001; de Cian et al., 2008).  
Indeed, the intramolecular telomeric G-quadruplex (Neidle & Parkinson, 2003; Dai et al., 
2008) has been considered to be an attractive target for anticancer drug design since 
quadruplex ligands were found to inhibit telomerase (Sun et al., 1997; Zahler et al., 1991; 
Zaug et al., 2005). However genomic analyses using several algorithms have revealed that 
more than 370 000 sequences have the potential to form G-quadruplex structure in the 
human genome (Huppert & Balasubramanian, 2005; Huppert, 2008). Indeed, many G-rich 
sequences in the human genome are susceptible to the formation of a G-quadruplex (e.g. 
ribosomal RNA, repetitive G-rich microsatellites and the promoters of several proto-
oncogenes including c-MYC and c-KIT) (Maizels, 2006; Eddy & Maizels, 2008; Huppert & 
Balasubramanian, 2005 and 2007; Todd et al., 2005 and 2007; Qin & Hurley, 2008; Siddiqui-
Jain et al., 2002; Phan et al., 2004; Yang & Hurley, 2006; Rankin et al., 2005; Fernando et al., 
2006; Shirude et al., 2006). Several proteins have been reported to interact and/or resolve 
such unusual DNA conformations (Hurley, 2002; Bates et al., 2007; Oganesian & Bryan, 
2007; Fry, 2007) supporting the existence of a G-quadruplex. Thus, G-quadruplex ligands 
have to selectively bind to and stabilize telomeric G-quadruplexes to inhibit telomerase 
activity. Many quadruplex ligands have now been identified such as telomestatin, 
BRACO19, TMPyP4 and RHSP4 (Monchaud et al., 2008; Gowan et al., 2002; Han et al., 2001; 
Gavathiotis et al., 2003; Shin Ya et al., 2001; de Cian et al., 2008), all selected in vitro for their 
ability to interact with telomeric G-quadruplex. However, many new compounds are likely 
to be discovered in the future (Bates et al., 2007). In this context, we have investigated 
chromosomal binding and the cellular effects induced by new pyridine-derived G-
quadruplex ligands of the 2,6 pyridine-dicarboxamide series in human normal and tumour 
cells, and also in ATM- and ATR- (Ataxia Telangiectasia-mutated and Rad3-related) 
deficient cells. Pyridine derivatives that function as G-quadruplex ligands were selected in 
vitro on the basis of their ability to interact with a telomeric G-quadruplex (∆Tm values of 21 
– 26 °C) and to inhibit telomerase (IC50 values of 0,22 - 0,45 µM) (Pennarun et al., 2005). 
Among these new compounds, 307A and 360A (Figure 4) displayed the best compromise 
between activity and selectivity in vitro. Finally, we chose 360A as it is the most toxic G-
quadruplex ligand in human normal cells (Pennarun et al., 2005). 
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Fig. 4. Chemical formula of the G-quadruplex ligands, 307A and 360A. 
2. In vivo binding of G-quadruplex ligand 360A  
The existence of G-quadruplexes was shown in vitro many years ago (Wang & Patel, 1993; 
Parkinson et al., 2002; Neidle & Parkinson, 2003), but it has not yet been definitively 
demonstrated that G-quadruplexes exist in vivo, apart from Escherichia coli (Duquette et al., 
2004) by electron microscopy and ciliates (Schaffitzel et al., 2001 and 2010) using an 
antibodies specific for telomeric guanine-quadruplex DNA. The replication band, which is 
the region where replication and telomere elongation take place, is not stained suggesting 
that G-quadruplexes are resolved during replication. In human cells, G-quadruplex-
interacting proteins (Oganesian & Bryan, 2007), the physiological relevance of G-
quadruplexes at the telomere (Phatak & Burger, 2007; Qin & Hurley, 2008), and in vitro 
studies (Su et al., 2010; Yang et al., 2009) strongly support the in vivo existence of such 
structures at the telomere. BMVC (3,6-bis(&-methyl-4-vinylpyridinium)carbazole diiodide) 
has a high sensitivity and binding preference for quadruplex d(TTAGGG)4 over duplex 
DNA (Chang et al., 2004). By analyzing BMVC fluorescence at the ends of metaphase 
chromosomes and other regions of chromosomes, Chang et al. have shown the presence of 
G-quadruplexes in the human genome and in telomere-proximal regions (Chang et al., 
2004). G-quadruplex ligands were selected in vitro on the basis of their highly selective 
interactions with telomeric G-quadruplexes and for their potent inhibitory effects on 
telomerase.  
Because the in vivo existence of G-quadruplex is still unresolved, we investigated the 
targeting in human normal and cancer cells by the G-quadruplex ligand using tritiated-360A 
(3H-360A) (Granotier et al., 2005). The selectivity of 3H-360A for G-quadruplex was first 
checked in vitro using competitive equilibrium dialysis (Granotier et al., 2005). The binding 
of 3H-360A to purified genomic DNA was then determined by competition experiments 
with various oligonucleotides and the results highlighted that 3H-360A has a preference for 
G-quadruplex. Interestingly, the addition of oligonucleotide that hybridized to the telomeric 
G-overhang decreased the binding of 3H-360A, suggesting that at least 35% of 3H-360A 
bound to genomic DNA at the telomeric G-overhang (Granotier et al., 2005). G-quadruplex 
formation would be more likely on the 3’ telomeric overhang because the Watson-Crick 
double helix is the predominant DNA form under physiological conditions. Interaction of G-
quadruplex ligand and the telomeric single-strand overhang have been reported for 
telomestatin (Gomez et al., 2004). In agreement with this, DMS footprinting and exonuclease 
hydrolysis has revealed that G-quadruplex preferentially forms at the very 3’ end of the 
telomeric DNA (Tang et al., 2008). Using this method, it will be interesting in the future to 
analyze the position of the G-quadruplex stabilized by 360A. Indeed, G-quadruplex 
formation at the very 3’ end of the chromosome may be a regulatory mechanism at the 
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telomeric overhang that mediates T-loop formation, DNA repair and telomere maintenance 
by telomerase and/or ALT.  
Autoradiography has been used previously to investigate the distribution of tritium using a 
liquid emulsion, NTB2. Charged particles from tritium (β-rays) interact with a silver halide 
crystal of the autoradiography emulsion. This interaction induces the formation of a latent 
image within the crystal, initiating the formation of silver grains during subsequent 
photographic development of the emulsion (Boren et al., 1975). Thus, by autoradiography of 
cancer cells cultured with 3H-360A, we were able to show previously in our laboratory that 
the G-quadruplex ligand enters the cells within six hours of the start of treatment and 
progressively accumulate in the nuclei of living cells (Figure 5A and Granotier et al., 2005). 
Autoradiography of metaphase spreads from cancer cells treated with 3H-360A (T98G cells 
with short telomeres and CEM1301 cells with long telomeres) demonstrated that the silver 
grain density was significantly higher at the ends of the chromosomes than at the interstitial 
regions, thus highlighting that the G-quadruplex ligand preferentially bound to the terminal 
regions of the chromosomes (Figure 5B and 5C and Granotier et al., 2005). Interestingly, 
autoradiographs of the CEM1301 cells that have very long telomeres did not show a greater 
silver grain density at the ends of chromosomes compared with T98G cells (Figure 5C) 
revealing that the frequency of binding of 3H-360A to chromosome ends does not appear to 
depend on telomere length and supporting the idea that 3H-360A might be bound to 
telomeric overhangs (Granotier et al., 2005). The G-quadruplex ligand specifically interacts 
with the terminal regions of chromosomes but we cannot rule out the possibility of specific 
binding sites located in interstitial sequences. Indeed G-quadruplexes have been shown to 
exist in other physiologically important G-rich regions (Siddiquin-Jain et al., 2002; Xu et al., 
2006; Sun et al., 2005; de Armond et al., 2005; Todd et al., 2007, Huppert, 2008). 
RNase treatment of metaphase spreads decreased the number of silver grains (data not 
shown) suggesting that 360A also binds RNA, in accordance with the existence of an RNA 
G-quadruplex (Phan & Patel, 2003; Kumari et al., 2007; Huppert, 2008). Nevertheless, 
autoradiography analysis of metaphase spreads treated with RNase provided evidence that 
3H-360A binds to telomeric DNA quadruplex at the ends of chromosomes, but not to 
telomeric repeat-containing RNA (TERRA) (Azzalin et al., 2007; Azzalin & Lingner, 2008; Ho 
et al., 2008). Indeed, Azzalin et al. have shown previously that UUAGGG-containing RNA 
exists in cells at higher levels than complementary CCCUAA-containing RNA. High levels 
of UUUAGGG-containing RNA might result from the strong RNA resistance induced by G-
quadruplex formation (Xu et al., 2008). Using a light-switching pyrene probe, Xu et al. have 
now demonstrated that human TERRA RNA forms a G-quadruplex structure in living cells 
(Xu et al., 2010) and hence we cannot exclude the possibility that 3H-360A binds to the RNA 
G-quadruplexes located at the telomeres. 
Autoradiography has revealed G-quadruplexes in interphase nuclei and in metaphase 
spreads, suggesting that their existence is not restricted to only one phase of the cell cycle. 
Telomere replication and T-loop resolution also do not seem to interfere with the formation 
and/or the stabilization of G-quadruplex but it is presently unclear whether a T-loop and G-
quadruplex can form on the same telomere.  
Silver grain densities were found again to be significantly higher at the ends of 
chromosomes in PHA-activated PBL cells from a healthy donor (Figure 5C), indicating the 
preferential binding of 3H-360A to terminal regions of chromosomes from normal as well as 
cancer cells (Granotier et al., 2005).  
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Fig. 5. Detection of 3H-360A by autoradiography in human cancer and normal cells. A: 
Autoradiographs of T98G glioblastoma cells cultured without (Control) or with 3H-360A for 
24h and showing accumulation of the radioactive compound in the nuclei stained with 
Mayer’s hemalun solution. B: Autoradiography of metaphase chromosomes from T98G cells 
cultured with 3H-360A for 48 h. Black arrows indicate silver grains on the terminal regions 
and red arrows indicate silver grains on the interstitial regions. C: Densities of silver grains 
on ternimal (T) and interstitial (I) regions of chromosomes from T98G (short telomeres) and 
CEM1301 (long telomeres) and normal cells (PBL, peripheral blood lymphocytes PHA-p 
stimulated). Silver grains were counted in 25 metaphases/group for the untreated control 
and in 50 metaphases/group for cultures incubated with 3H-360A. I values were normalized 
to areas of terminal regions by dividing the total numbers of grains on the interstitial 
regions in each metaphase by the mean ratio of the interstitial and terminal areas estimated 
by Metamorph software (T98G: 2.93 ± 0.44 at 24 h, n = 20; 3.52 ± 0.48 at 48 h, n = 20 and 3.34 
± 0.29 at 72 h, n = 20 ; CEM1301: 3.03 ± 0.44, n = 12 ; PBL: 3.64 ± 0.87, n = 20). Boxes include 
50% of the values centred on the median (the horizontal line through the box). The vertical 
lines begin at the 10th percentile and end at the 90th percentile. T values were significantly 
greater than I values: *t-test P < 0.0001. 
Overall, autoradiography analysis of metaphase spreads has revealed that 3H-360A binds to 
telomeres, indicating G-quadruplex formation. However, this result might be an under-
estimation of this binding because not all the decays can be detected by this method. In vitro 
studies have indicated the polymorphic nature of the telomeric G-quadruplex (Dai et al., 
2008), and the 3H-360A ligand may therefore be unable to bind all the G-quadruplex 
structural conformations. In addition, 3H-360A is naturally unstable due to progressive 
radiolysis, so we cannot totally exclude a partial degradation of this G-quadruplex ligand. 
We have shown elsewhere that tritium induces DNA damage and/or cell cycle alterations 
so that the metaphase spreads analyzed could be from the cells less affected by the G-
quadruplex ligand. G-quadruplex elimination by the DNA repair machinery might also 
explain that not all telomeres are detected with silver grains. 
Previous findings from our laboratory revealed that a specific G-quadruplex ligand interacts 
with the terminal ends of human chromosomes and support the hypothesis that G-
quadruplex ligands induce and/or stabilize G-quadruplex structures at the telomeres in 
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both human normal and cancer cells. Fluorescence titration experiments with 
oligonucleotides have demonstrated that 360A might actively induce the formation of a 
tetramolecular quadruplex, acting as a chaperone for the association of the four strands (de 
Cian & Mergny, 2007), therefore highlighting that 360A triggers G-quadruplex formation 
and locks it into a preformed structure. We have also shown by autoradiography that the G-
quadruplex ligand (360A) binds preferentially to the terminal regions of chromosomes in 
tumour and normal cells (Granotier et al., 2005). This led us to investigate the cellular effects 
induced by 360A in cancer cells. 
3. Cellular effects induced by the G-quadruplex ligand 360A in human cancer 
cells 
3.1 G-quadruplex ligands reduce viability and induce apoptosis in both telomerase-
positive and ALT cancer cells 
We have reported previously that pyridine derivatives displaying strong selectivity for G-
quadruplex structures inhibit cell proliferation in telomerase-positive tumour cells and 
induce apoptosis after more than three population doublings (Pennarun et al., 2005 and 
2008). This is similar to the effects of other G-quadruplex ligands (telomestatin, TMPyP4, 
RHSP4 and BRACO19) (Phatak & Burger, 2007; Tahara et al., 2006; Gomez et al., 2004; Incles 
et al., 2004; Gowan et al., 2002). In these earlier studies, cancer cells were treated with several 
doses of G-quadruplex ligands (ranging from 1 to 5 µM for telomestatin, RHSP4 and 
BRACO19 and from 50 to 100 µM for TMPyP4). Comparisions of the effects of these ligands 
is problematic however as they were evaluated in different cancer cell lines. It will be 
important therefore to compare the inhibition of cell proliferation by various G-quadruplex 
ligands in the same cancer cell types. 
3.1.1 The action of the G-quadruplex ligands is independent of telomerase inhibition 
We have shown that 360A blocks cell proliferation and induces apoptosis in ALT tumour 
cells, suggesting that this G-quadruplex ligand does not only inhibit telomerase activity 
(Pennarun et al., 2005). Consistently, other G-quadruplex ligands (TMPyP4, RHSP4, 
BRACO19) have also been shown to inhibit cell proliferation in ALT cells (Kim et al., 2003; 
Gowan et al., 2001; Incles et al., 2004; de Cian et al., 2008), although telomestatin does not do 
so (Kim et al., 2003). Moreover, the overexpression of hTERT or a dominant-negative of 
hTERT in telomerase-positive cell lines does not modify the anti-proliferative effects of the 
triazine derivative, 12459, (de Cian et al., 2008) indicating that the suppression of cell growth 
by G-quadruplex ligands is independent of its function in telomerase inhibition. Consistent 
with this, we have further shown that active pyridine derivatives require several rounds of 
replication to induce cell growth arrest.  
Flow cytometry analysis have shown that the treatment of cancer cells with a G-quadruplex 
ligand induces a marked decrease in the percentage of cells in G0/G1 phase, dramatically 
increases the percentage of cells in S phase and also in sub-G1, indicating that 360A induces 
cell death in cancer cells. The detection of TUNEL-positive cells (Pennarun et al. 2005) in 
360A-treated telomerase positive- and ALT cells confirmed that this G-quadruplex ligand 
induces apotosis in human cancer cells regardless of the status of their telomere 
maintenance mechanism.  
The effectiveness of the G-quadruplex ligand depends more on its specificity for the G-
quadruplex structure. In vitro studies have found that 360A more actively induces the G-
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quadruplex structure compared with other G-quadruplex ligands tested (telomestatin, 
TMPyP4 and BRACO19) (de Cian & Mergny, 2007). G-quadruplex ligands lock into the G-
quadruplex structure but this situation is complicated by the existence of a number of 
different G-quadruplex structures (dimeric, tetrameric, intra- or inter-molecular). TMPyP4, 
that facilitates the formation of intermolecular G-quadruplex structures, suppresses the 
proliferation of ALT cells and telomerase-positive cells whereas telomestatin, which 
promotes the formation of intramolecular G-quadruplex, only suppresses the proliferation 
of telomerase-positive cells (Kim et al., 2003). TMPyP4 induces anaphase bridges in sea 
urchin embryos whereas telomestatin does not have this effect (Kim 2003) suggesting that 
the selectivity of G-quadruplex ligands for intra- or inter-molecular structures is important 
for their biological effects. It will be interesting in the future to analyze the selectivity of 
360A by electrophoretic mobility shift assay (Kim et al., 2003) or by fluorescent screening 
method (Paramasivan & Bolton, 2008) using multiple reporter molecules that bind to 
different features of quadruplex DNA. 
3.1.2 360A does not induce telomere shortening but provokes telomeric overhang 
degradation 
360A was found not to induce telomere shortening in our previous analysis (Pennarun et al., 
2005). Indeed, Southern blot analysis has revealed no significant change in the mean TRF 
(Telomere Restriction Fragment) lengths in cells treated with this G-quadruplex ligand, 
although the possibility that this treatment may have caused slight telomere erosion could 
not be excluded. In contrast, BRACO19 and TMPyP4 treatments shorten telomeres whereas 
telomestatin and RHPS4 do not do so. In highlighting that G-quadruplex ligands do not act 
as telomerase inhibitors these data suggest that they induce telomere deprotection. The 
inhibition of cell proliferation induced by G-quadruplex ligands in ALT cells and in 
CEM1301 cells with long telomeres (data not shown) confirms that G-quadruplex ligand 
targets telomeres independently of any effects upon telomerase activity.  
In any case, the inhibition of cancer cell proliferation is not due to telomere shortening induced 
by G-quadruplex stabilization but could be triggered by telomeric overhang degradation. 
Indeed, non-denaturing hybridization assays have revealed that a pyridine derivative induces 
an alteration of the length of telomeric G-overhang in cancer cells (Pennarun et al., 2005) in a 
manner similar to G-quadruplex ligands. Taken together, these data suggest that G-
quadruplex ligands destabilize telomere structures in human cancer cells. 
3.2 G-quadruplex ligands induce telomere deprotection and telomere aberrations in 
cancer cells involving lagging strand telomeres 
Giemsa staining of metaphase spreads from 360A-treated cancer cells has shown that G-
quadruplex ligands induce the formation of dicentric or ring chromosomes and anaphase 
bridges in telomerase-positive cancer cell lines (Pennarun et al., 2005). This confirms that 
pyridine derivatives acts at the telomeres and induce telomeric instabibility that is 
comparable to deprotected telomeres. Detection of chromosome dicentrics in 360A-treated 
CEM1301 cells with long telomeres has further indicated that genetic instability is not 
provoked by critically short telomeres providing new evidence that G-quadruplex ligands 
modify telomere structures.  
Indeed, we have shown by Telomere-Fluorescence in situ hybridization (Telo-FISH) and 
Chromosome Orientation-FISH (Bailey et al., 2004; Crabbe et al., 2004), that the G-
quadruplex ligands induce specific telomere aberrations (sister telomere fusions, sister 
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telomere losses and telomere doublets) either during or after replication (Figure 6) 
(Pennarun et al., 2008 and 2010). Telomere aberrations induced by a G-quadruplex ligand 
mainly consist of sister telomere fusions and also recombination preferentially involving the 
lagging strand telomeres (Pennarun et al., 2008).  
 
 
Fig. 6. Telomere aberrations revealed by CO-FISH in human cancer cells. Lagging strand 
telomeres are labelled in red and leading strand telomeres in green. Representative 
examples of a control chromosome (A), a sister telomere fusion (B), a sister telomere loss 
involving the lagging strand (C) and a telomere doublet involving the lagging strand (D) are 
shown.  
Delocalization of telomeric proteins (for example POT1 and TRF2) from the telomere 
induced by 360A (Figure 7A and 7B) and other G-quadruplex ligands (Tahara et al., 2006; 
Gomez et al., 2006; Salvati et al., 2007; Rizzo et al., 2009) and telomere aberrations induced 
by 360A in cancer cells confirmed that those compounds provoke telomere deprotection 
events and not just the inhibition of telomerase. Rizzo et al. have provided evidence that 
RHSP4 damages telomeric chromatin during replication (Rizzo et al., 2009), confirming the 
results from our laboratory. 
 
 
Fig. 7. TRF2 delocalization from the telomere revealed by immunostaining with anti-TRF2 
antibody (green) in CEM1301 cancer cells treated for 8 days with 5 µM 360A or 0.05% 
DMSO. Nuclei and metaphase chromosomes were counterstained with DAPI (blue). 
Histograms show the mean number of TFR2 foci per nucleus (A) and the mean number of 
telomeres on metaphase chromosomes with TRF2 foci ± SE (B). 
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360A has been shown to stabilize the G4 structure within the TRF2 mRNA thereby 
repressing the expression of this telomeric protein (Gomez et al., 2010). By interacting with 
supercoiled DNA and participating to the formation and to the dissolution of the T-loop, 
TRF2 is essential for telomere replication. Therefore the decrease of TRF2 may reduce the 
presence of this telomeric protein at telomeres leading to dysfunctional telomeres. 
Taken together, these data reveal that G-quadruplex ligands inhibit cell proliferation and 
stimulate apoptosis by inducing a broad spectrum of telomere aberrations and telomere 
deprotection in human cancer cells.  
3.3 Increase in telomere aberrations in 360A-treated ATM- or ATR-deficient cells 
Deprotection of the telomere is known to induce DNA damage response pathways leading 
to cell cycle arrest, genomic instability, apoptosis or senescence. In addition, several DNA 
damage response factors (e.g. ATM) are involved in telomere replication and in the 
formation of a T-loop in the S and G2 phases. ATR, another key protein involved in the 
DNA damage response, is essential for maintenance of genomic stability. ATR belongs to a 
family of phosphatidyl-linosisitide 3-kinase-like kinases, which includes ATM (Cimprich & 
Cortez, 2008). ATM is primarily activated by DNA double-stranded breaks, whereas ATR 
responds to a broad spectrum of DNA damage events, in particular those interfering with 
DNA replication. In that context, we investigated the cellular effects of 360A in ATM- and 
ATR-deficient cells. In cancer cells, immunofluorescence staining showed that 360A induces 
DNA damage signals (γ-H2AX foci) in a strictly ATM-dependent manner (Pennarun et al., 
2008) similar to telomestatin (Tauchi et al., 2003), thus showing that G-quadruplex 
stabilization induces telomere deprotection. However, in cells treated with 360A, nuclear 
foci of 53BP1 only partly co-localize with PNA telomeric signals, indicating that G-
quadruplex ligands, such as telomestatin (Bates et al., 2007), induce other DNA damage 
events at interstitial sites.  
We have further characterized the biological effects of 360A in stable cells expressing siRNA 
molecules that target ATM or ATR. We have found that ATM, which is involved in the cellular 
response to DNA damage, strongly suppresses 360A-induced telomere instability (Pennarun 
et al., 2008). The increase in telomere aberrations in 360A-treated ATM deficient cells were 
found not to be related to defects in cell cycle checkpoints or to apoptosis induction, 
suggesting a direct role of ATM in preventing inappropriate DNA repair at the telomeres.  
We have further reported that an ATR deficiency causes telomere instability both in primary 
human fibroblasts from Seckel syndrome patients and in HeLa cells (Pennarun et al., 2010). 
Telomere aberrations resulting from an ATR deficiency are mainly generated during and/or 
after telomere replication and involve both leading and lagging strand telomeres. Moreover, 
we have demonstrated that an ATR deficiency strongly sensitizes cells to the effects of the 
G-quadruplex ligand 360A, leading to enhanced sister fusions and chromatid-type telomere 
aberrations involving specifically the lagging strand telomere. RHSP4 has also been found to 
induce an ATR dependent ATM signalling (Rizzo et al., 2009) consistent with our results. 
These data emphasize that ATR also plays a critical role in telomere maintenance during 
and/or after telomere replication in human cells.  
The increase in telomere instability that we observed in ATM- and in ATR-deficient cells 
treated with G-quadruplex ligand indicates the importance of ATM and ATR and suggests 
that key proteins implicated in the DNA damage response also contribute to telomere 
stability during and/or after replication, thus playing an important role in human telomere 
maintenance.  
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4. Effects of the G-quadruplex ligand 360A in human normal cells 
G-quadruplex ligands inhibit cellular proliferation, and provoke cell cycle arrest and apoptosis 
by inducing telomere aberrations and telomere deprotection, i.e. they do not only function as a 
telomerase inhibitor. We previously observed that after seven days of treatment, no effects of 
G-quadruplex ligands could be found in primary astrocyte cultures (Pennarun et al., 2005), 
suggesting a differential effect of these factors in cancer and normal cells. In most somatic cells, 
telomerase activity is not detectable whereas telomerase is expressed in highly proliferative 
cells such as germ cells and stem cells. In this context, we investigated the cellular effects 
induced by 360A in human telomerase-positive (PBL, peripheral blood lymphocytes PHA-p 
stimulated) and telomerase-negative normal cells (NHF27 fibroblasts). It is noteworthy 
however that in normal fibroblasts, a transient expression of hTERT and very low telomerase 
activity can be detected during S phase (Masutomi et al., 2003). The telomerase activity 
detected in primary fibroblasts during S phase is considerably lower than that in cancer cells 
and other normal cells (such as activated lymphocytes). In normal cells, telomere maintenance 
by telomerase activity impedes replicative senescence but telomerase activity decreases with 
age, thereby inducing a telomere shortening.  
4.1 The G-quadruplex ligand 360A marginally represses the proliferation of normal 
cells and can induce premature senescence 
We previously observed that after seven days of treatment, no effect of G-quadruplex 
ligands was evident in primary astrocyte cultures (Pennarun et al., 2005). This result was 
confirmed by assessing the effects of this treatment on the population doublings in long-
term cultures. Peripheral blood lymphocytes isolated from 15 healthy volunteers, and 
stimulated with PHA-p and IL2 (Interleukine 2) were treated with 360A. For long-term 
exposure studies, these cells were grown in flasks and exposed to 360A at various 
concentrations (1, 5 and 10 µM). Control cells were treated with the corresponding 
concentrations of DMSO (0.01, 0.05 and 0.1%). Every 3-4 days, the cells were counted using 
trypan blue, and then reseeded with fresh medium containing a new dose of compound. 
Indeed, the 1 µM dose of 360A was found not to decrease the rate of PBL proliferation 
(Figure 8), whereas this concentration dramatically reduced proliferation and induced cell 
death in cancer cells (Pennarun et al., 2005; 2008 and 2010). Higher concentrations of 360A (5 
and 10 µM) slightly decreased PBL proliferation in a donor-dependent manner (Figure 8).  
 
 
Fig. 8. Cell growth curves for PBLs isolated from the fresh blood samples of normal 
volunteers (one colour per donor) and cultured with 1, 5 and 10 µM 360A () or the 
corresponding concentrations of DMSO (). 
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In telomerase-positive cancer cells, 360A induces apoptosis after 12-14 days, (2-5 population 
doublings) (Pennarun et al., 2005; 2008 and 2010). After 14 days of treatment, DMSO had no 
effect on the mean population doubling time of PBLs (4.94 ± 0.55 for 0.01% – 4.96 ± 0.46 for 
0.05% and 4.77 ± 0.33 for 0.1%), whereas 360A slightly decreased this rate (4.52 ± 0.36 for 1 
µM, 3.31 ± 0.31 for 5 µM and 2.90 ± 0.59 for 10 µM). This result emphasizes that the lack of 
apoptosis in 360A-treated normal cells is not linked to their reduced cell proliferation 
compared with cancer cells. Autoradiography analysis have previously demonstrated the 
preferential binding of the G-quadruplex ligand to the chromosome ends of PBLs (Granotier 
et al., 2005), thus providing evidence that the differential effects of the G-quadruplex ligand 
in human normal cells is not linked to the lack of binding of 360A.  
We found that 360A slightly decreases the rate of PBL proliferation without inducing cell 
cycle arrest (analyzed by propidium iodide staining and FACS, Figure 9). Determination of 
the cellular DNA content by flow cytometry shows that the G-quadruplex ligand induces a 
gradual increase in the percentage of cells in G1 phase over time in treated populations of 
PBLs (Figure 4). By TUNEL staining and sub-G1 quantification by FACS we have further 
found that 360A does not induce cell death in PBLs. Indeed, our TUNEL assay results reveal 
less than 5% of PBLs treated with 1, 5 and 10 µM 360A or the corresponding concentrations 
of DMSO for 13 days are apoptotic (data not shown). 
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Fig. 9. Cell cycle analysis of PBLs cultured with 1, 5 and 10 µM 360A or 0.1% DMSO for 7, 10, 
14 and 17 days. The percentages of cells in different phases of the cell cycle are expressed 
with respect to the total number of viable cells (corresponding to an analysis of 105 cells). 
Histograms are representative of two independent experiments. 
In telomerase-negative normal cells, a WST assay revealed a reduced effect of 360A in primary 
NHF27 fibroblasts (IC50 > 16 µM) so we further characterized the biological effects of 360A by 
assessing population doublings in long-term cultures. Primary fibroblasts were treated with 1 
and 5 µM 360A or the corresponding concentrations of DMSO (Figure 10A). A 20 day 
treatment with 1 and 5 µM of 360A slightly reduced the proliferation of primary fibroblasts in 
a dose-dependent manner without inducing cell death. After 50 days of treatment, 360A 
reduced the mean doubling population of primary fibroblasts (6 and 18 population doublings 
for 360A- and DMSO-treated NHF27 respectively). Moreover, telomerase-negative primary 
fibroblasts treated with 1 µM of 360A can be maintained in culture for 50 days without cell 
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death, highlighting the fact that 360A decreases cell viability and/or cell proliferation in 
telomerase-positive cancer cell lines, whereas telomerase-positive and telomerase-negative 
human normal cells are more resistant to G-quadruplex ligand treatment. 
 
 
Fig. 10. Proliferation and morphology of primary fibroblasts treated with G-quadruplex 
ligand 360A or DMSO. A: Representative cell growth curves for primary fibroblasts cultured 
with various concentrations of 360A (1 and 5 µM) or the corresponding concentrations of 
DMSO (0.01% and 0.05%). Mean population doublings from duplicate cultures ± standard 
deviation, are representative of four independent experiments. B: Phase-contrast 
micrographs showing the cellular morphology of primary fibroblasts treated with 0.05% 
DMSO (left, *10 objective) or 5 µM 360A (middle, *10 objective and right, *20 objective). 
Light microscopy revealed a decrease in the cell density and morphological changes that 
became detectable after about 20 days of treatment. Indeed, treated primary fibroblasts 
exhibited a typical senescent phenotype with a flattened and enlarged cell shape (Figure 10B). 
By propidium iodide staining and FACS analysis, we analysed the progression of primary 
fibroblasts treated with 1 and 5 µM of 360A or the corresponding concentrations of DMSO 
for 10, 14, 22 and 29 days. The G-quadruplex ligand was found not to increase the 
percentage of cells in S-phase as in cancer cells populations, or the percentage of cells in G1-
phase such as in PBLs but did increase the percentage of cells in G2/M phase (Figure 11) 
without increasing the percentage of cells in sub-G1 phase. This confirmed the lack of a cell 
death in 360A-treated primary fibroblasts.  
The induction of senescence was confirmed by the detection of senescent associated β–
galactosidase-positive cells at pH6.0, an established senescence marker (Dimri et al., 1995) 
(Figure 12A). 
At day 19, we detected 35.4 ± 15.2 and 61.7 ± 2.3% of senescent cells in primary fibroblast 
cultures treated with 1 and 5 µM 360A, respectively, and a 1.8 ± 0.6% of senescent cells in 
DMSO-treated primary fibroblasts (Figure 12B), thus showing that G-quadruplex ligand 
does not induce apoptosis but premature senescence in normal cells in a dose-dependent 
manner. Some G-quadruplex ligands (e.g. telomestatin, BRACO19, RHPS4) but nor all 
(TMPyP4) show selective toxicity towards cancer cells (Gomez et al., 2006; Cheng et al., 
2007; Salvati et al., 2007; Rha et al., 2000). Indeed TMPyP4 inhibits the cell proliferation of 
normal cells (fibroblasts, adult keratinocytes and epithelial cells) and cancer cells 
(neuroblastoma, breast cancer, cervical cancer, pancreatic cancer, colon cancer and a prostate 
cancer cell line) (Rha et al., 2000). The slow growth of normal cells versus the rapid 
proliferation of tumour cells may be involved in the selective toxicity of G-quadruplex 
ligand. But we have found that 360A does not induce cell death in normal cells and Salvati 
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et al, have further reported that highly proliferating human peripheral blood lymphocytes 
are resistant to RHPS4 suggesting that growth rate is not the main cause of G-quadruplex 
ligand tumour selectivity (Salvati et al., 2007).  
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Fig. 11. Cell cycle analysis of primary fibroblasts cultured with 1 and 5 µM 360A or 0.05% 
DMSO for 10, 14, 22 and 29 days. The percentages of cells in different phases of the cell cycle 
are expressed with the respect to the total number of viable cells (corresponding to an 
analysis of 105 cells). Histograms show the mean of duplicate cultures and are representative 
of three independent experiments. 
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Fig. 12. Premature senescence induced by G-quadruplex ligand in primary fibroblasts 
cultured with 1 or 5 µM 360A or the corresponding concentration of DMSO for 19 days. A: 
Senescent associated-β galactosidase staining (blue) of senescent cells. Nuclei were stained 
with propidium iodide (red). B: Histograms showing the percentage of senescent cells (150-
550 nuclei analyzed per condition). 
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G-quadruplex ligands induced premature senescence in primary fibroblasts but no cell death. 
Masutomi et al. have detected low levels of telomerase activity in primary fibroblasts during S 
phase. The disruption of telomerase activity in human primary fibroblasts slows down 
proliferation, alters the maintenance of the 3’ single-stranded telomeric overhangs and induces 
senescence without cell death (Masutomi et al., 2003) suggesting that the periodic expression 
of hTERT benefits cell proliferation and delays the onset of replicative senescence. Because 
360A induces a premature senescence, this G-quadruplex ligand may inhibit transient 
telomerase activity in normal cells. It was therefore of interest to evaluate the transient 
telomerase activity levels in 360A-treated primary fibroblasts during S phase. To this end, we 
analyzed BJ-TERT cells, primary human fibroblasts with long telomeres immortalized through 
the stable expression of the catalytic component of human telomerase (Jiang et al., 1999). Our 
results showed that 360A-treated BJ-TERT cells are more resistant to this ligand than primary 
fibroblasts. Indeed, BJ-TERT cells treated with 5 µM of 360A can be maintained in culture for 
34 days without any evidence of premature senescence (<5% of senescent cells) confirming the 
link between telomerase activity and G-quadruplex resistance in normal cells. 
We have previously shown by autoradiography that 360A binds preferentially to the 
terminal regions of chromosomes in human cancer and normal cells (Granotier et al., 2005), 
supporting the hypothesis for the in vivo formation of G-quadruplexes at the telomeres of 
these cells. The differential effects of 360A in normal and cancer cells are not linked to the 
lack of a G-quadruplex and/or the lack of 360A binding in normal cells. Nevertheless, we 
cannot at this stage exclude G-quadruplex structure variation and/or the differential 
regulation of G-quadruplexes during cell cycle progression between normal and cancer cells 
In vitro studies using oligonucleotides have given some insights into the structural 
polymorphisms of the G-quadruplex. (Hurley, 2002; Bates et al., 2007; Oganesian & Bryan, 
2007; Dai et al., 2008). These polymorphisms and the dynamic equilibrium of telomeric G-
quadruplexes, between human normal and cancer cells, may be important for 
considerations for the design of future therapeutic interventions. 
Finally, we analyzed the proliferation of cancer cells (human glioblastoma, T98G) and 
normal cells (primary fibroblasts, NH27) at the end of a 360A treatment. T98G cells and 
primary fibroblasts were cultured with 1 and 5 µM 360A or the corresponding concentration 
of DMSO for several days (4 and 7 days for T98G, 15 and 22 days for NHF27). After the 
treatment period had ended, T98G and NHF27 cells were cultured in medium without G-
quadruplex ligand until day 20 for T98G and day 50 for NHF27 (Figure 13).  
After treatment with 1 µM 360A, we observed a resumption of proliferation in T98G cells 
treated for 4 and 7 days (Figure 13A) and in NH27 cells treated for 15 and 22 days (Figure 
13B). After a treatment with 5 µM 360A, elimination of the G-quadruplex ligand at day 4 
provoked a resumption of proliferation in cancer cells, but elimination of 360A at day 7 did 
not do so (Figure 13C). However, elimination of this G-quadruplex ligand at the 5µM dose 
did induce the resumption of proliferation, even after 15 days of treatment (Figure 13D). In 
primary fibroblasts, the percentage of senescent cells decreased after the end of treatment, 
when we detected the resumption of proliferation (data not shown). We found that 360A 
also induced reversible premature senescence in primary fibroblasts but provoked apoptosis 
in cancer cells. Replicative senescence is thought to be an essentially irreversible growth 
arrest phenomenon but a p53-dependent reversible senescence pathway has been identified 
in normal cells as a response to dysfunctional telomeres (Beausejour et al., 2003; Dirac & 
Bernards, 2003). It will be of interest to study the implications of p53 function in normal cells 
treated with G-quadruplex ligand. 
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Fig. 13. Cell growth curves for T98G glioblastoma cells (A and C) and NHF27 primary 
fibroblasts (B and D) cultured with 1µM 360A (top), 5µM 360A (bottom) or the 
corresponding concentrations of DMSO. Cells were analyzed after the end of treatment at 
day 4 (stop D4) or day 7 (stop D7) for T98G cells and day 15 (stop D15) or day 22 (stop D22) 
for NHF27 cells. Mean population doublings from duplicate populations ± standard 
deviation are shown. 
4.2 The G-quadruplex ligand 360A does not induce telomere instability in normal 
human cells 
To gain further insight into the cellular effects of 360A in primary human normal cells, we 
analyzed genetic stability as an endpoint. We have previously shown that G-quadruplex 
ligands induce dicentric and ring chromosomes in telomerase-positive cancer cell lines 
(Pennarun et al., 2005). However, Giemsa staining of PBL chromosomes did not reveal 
chromatid breaks or dicentric chromosomes, suggesting that 360A does not induce 
chromosome instability in PBLs at a 1, 5 or 10 µM dose for 7, 10 and 15 days. Giemsa 
staining of primary fibroblasts chromosomes treated with 5 µM 360A for 7 days confirmed 
that this G-quadruplex ligand does not induce chromosome instability in normal cells.  
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We further characterized telomere stability in 360A-treated PBL and primary fibroblasts by 
telo-FISH after a 7 day treatment. In PBLs, we detected telomere aberrations (sister telomere 
fusions, sister telomere losses and telomere doublets) but their frequency remained stable in 
G-quadruplex ligand-treated normal cells (Figure 14A). We detected 9.1% ± 1.3 
chromosomes with telomere aberrations in 360A-treated PBLs (n=1387 chromosomes) and 
9.9% ± 1.1 chromosomes with abnormal telomeres in DMSO-treated PBL (n=1385 
chromosomes), indicating that 360A does not induce telomere instability in normal cells but 
does so in cancer cells (Pennarun et al., 2008 and 2010). It is noteworthy that the frequency of 
telomere aberrations in normal cells was found substantially lower than that in cancer cells. 
Indeed, Telo-FISH analysis revealed 2.98 ± 0.36 damaged telomere in 360-treated PBLs and 
2.98 ± 0.34 in DMSO-treated PBLs (Figure 14B), highlighting that this G-quadruplex ligand 
does not induce telomere aberrations in human primary peripheral cells. Autoradiography 
analysis of metaphase spreads of PBLs treated with 3H-360A further demonstrated the 
preferential binding of this G-quadruplex ligand to the terminal regions of chromosomes 
(Granotier et al., 2005) suggesting that the selective toxicity of 360A is not due to its lack of 
binding to telomeres in normal cells. 
Telo-FISH of primary fibroblast cultures treated with 360A for seven days (data not shown) 
further confirmed that this G-quadruplex ligand does not induce telomere instability in 
human normal cells, in contrast with the cancer cells. RHPS4, is another G-quadruplex 
ligand that does not induce telomere aberration in normal fibroblasts (Salvati et al., 2007) 
further suggesting that the telomere organization and the cellular response to damaged 
telomeres is substantially different between normal and cancer cells.  
 
 
Fig. 14. The G-quadruplex ligand 360A does not induce telomere aberrations in primary 
blood lymphocytes at a 5 µM 360A dose in a 7 day culture. A: Example of telomere 
evidenced by Telo-FISH in normal cells (a-d): control chromosome (a), sister telomere fusion 
(b), telomere doublet (c) and sister telomere loss (d). B: Histograms showing the percentage 
of chromosomes with telomere aberrations (sister telomere fusions, sister telomere losses, 
and telomere doublets) ± standard error (n=32-34 metaphases analyzed per condition). C: 
Box graphs showing the percentage distribution of damaged telomeres in DMSO- and in 
360A-treated PBLs for seven days. Boxes include 50% of the values centred on the median 
(the horizontal line through the box). The vertical lines begin at the 10th percentile and end 
at the 90th percentile.  
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5. Discussion 
Taken together, our results demonstrate that even at elevated concentrations, the G-
quadruplex ligand 360A has limited effects on the proliferation of normal cells, in which 
they do not induce apoptosis. Interestingly, we found that 360A induces reversible 
premature senescence in primary human fibroblasts. We mainly observed that this G-
quadruplex ligand does not induce telomere aberrations in normal human telomerase-
positive and telomerase-negative cells, highlighting the differential effects of this ligand in 
human normal and cancer cells (Table 1).  
The cellular effects induced by this G-quadruplex ligand suggest that the organization 
and/or cellular responses activated by damaged telomeres differ significantly between 
human normal and cancer cells. 
5.1 Telomere organization in the nucleus  
Telomere organization is cell cycle dependent, with the assembly of telomeres into a 
telomeric disk in the centre of the nucleus occurring in G2 phase in normal cells (primary 
human lymphocytes, primary human fibroblasts and normal human epithelial tissue) 
(Chuang et al., 2004). Telomeres are widely distributed throughout the nucleus in the 
G0/G1 and S phases. Moreover, the three dimensional telomere organization is distorted in 
tumour cells and telomeric aggregates are thus formed. Transient telomeric aggregations 
that potentially cause irreversible chromosomal rearrangements are suggestive of genomic 
instability. The spatial organization and distribution of telomeres in the nucleus, and during 
the cell cycle, are important for genomic stability. On the other hand the telomere 
organization in the nucleus of cancer cells could promote the chromosome instability 
induced by G-quadruplex ligands. Hence, it will be very interesting in the future to 
investigate telomere organization in normal and cancer cells treated with G-quadruplex 
ligands to evaluate whether G-quadruplex stabilization disrupts the three dimensional 
arrangement of the telomere organization in the nucleus. 
5.2 Telomeric 3’ overhang length 
At the very ends of the chromosomes, the telomeric 3’ overhang is critical for telomere 
elongation by telomerase, for forming the T-loop structure, and therefore for normal 
telomere function and genome stability (Rahman et al., 2008). Most cancer cell lines possess 
shorter overhangs whereas most normal cells have longer 3’ overhangs (Lee 2008). The size 
difference of the telomeric 3’ overhang between normal and cancer cells could explain the 
differential effects of the G-quadruplex ligand. Stabilization of G-quadruplexes by specific 
ligands along a long 3’ overhang in normal cells would not prevent the formation of the T-
loop. We can also speculate that G-quadruplex resolution by endonucleases and/or 
helicases would leave a sufficiently long overhang for normal telomere function. In this 
regard we have previously shown that 360A reduces the telomeric overhang in cancer cells 
(Pennarun et al., 2005). It will be now interesting to measure the 3’ overhang in human 
normal cells treated with G-quadruplex ligand using the previously described 
oligonucleotide ligation assay (Cimino-Reale et al., 2001). The telomerase inhibitor 
telomestatin, which is known to stabilize G-quadruplexes, preferentially inhibits the growth 
of cancer cells compared to normal cells (fibroblasts and epithelial cells). However, 
telomestain does not inhibit cell growth, does not reduce the telomeric overhang and does 
not induce the dissociation of TRF2 from telomeres in normal and hTERT-positive 
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fibroblasts (Tahara et al., 2006). We can thus hypothesize that there is a link between the lack 
of reduction of the telomeric 3’ overhang length, the TRF2 stability at telomeres and 
resistance to the effects of G-quadruplex ligands. 
5.3 Telomeric proteins  
Variations in the number of telomeric proteins fixed to double- or single-stranded telomeric 
DNA can modulate the sensitivity of cells to G-quadruplex ligands. In cancer cell lines, we 
have previously shown that 360A induces TRF2 delocalization from the telomeres but we 
don’t yet know if 360A also induces TRF2 delocalisation in normal cells. In any event, the G-
quadruplex ligands telomestatin and RHSP4 have been shown to induce TRF2 and POT1 
delocalization from the telomeres only in cancer cells (Tahara et al., 2006; Zaug et al., 2005; 
Salvati et al., 2007; Bates et al., 2007) without inducing TRF1 delocalization. The differential 
effects of telomestatin on TRF1 and TRF2 could be explained by their DNA-binding 
activities. Indeed, TRF1 binds to the telomere more strongly than TRF2 (Hanaoka et al., 
2005). The differential effects of telomestatin on TRF2 localization in cancer and normal cells 
could therefore be linked to different DNA-binding activities between these cell types. 
The telomere-disrupting agent telomestatin also induces a DNA damage response and 
apoptosis in newly generated neurons which have low levels of TRF2, whereas neural 
progenitor cells which have high levels of telomerase and mature neurons with high levels 
of TRF2 are resistant to telomere damage (Cheng et al., 2007). Finally, TRF2 or POT1 over-
expression correlates with the resistance to telomestatin and RHSP4 (Salvati et al., 2007; 
Cheng et al., 2007; Gomez et al., 2006). TRF2 might therefore counteract the effects of G-
quadruplex ligands through the formation of a T-loop that would mask the 3’ overhang and 
inhibit the recruitment of helicases which are expected to resolve G-quadruplexes and 
favour the binding of POT1 (Salvati et al., 2007; Opresko et al., 2002; O’Connor et al., 2006). 
Recently, Wang et al. have reported that the G-quadruplex formation at the 3’ end of 
telomeric DNA inhibits extension by telomerase and that the BLM helicase requires few 
nucleotides beyond the G-quadruplex for efficient unwinding (Wang et al., 2011). These 
data suggest that G-quadruplexes at the extreme 3’ end of a chromosome are resistant to the 
unwinding activity of helicases. The resistance of normal cells to 360A could therefore be 
due to the strong binding of TRF2 at the telomeres and/or the lack of TRF2 delocalization 
induced by G-quadruplex ligand.  
5.4 Cellular responses to damaged telomeres  
The cellular responses induced by damaged telomeres may significantly differ between 
normal and cancer cells. At the telomeres, the DNA damage response is activated by TRF2 
delocalization (Karlseder et al., 1999; van Steensel et al., 1998; Takai et al., 2003; Celli & de 
Lange, 2005). In cancer cells, immunofluorescence staining results have shown that 360A-
induced DNA damage signals occurs in a strictly ATM-dependent manner, but not in 
normal cells. Indeed, our own results indicate that 360A does not increase the number of γ-
H2AX foci in human primary lymphocytes, suggesting that the cellular response activated 
by damaged telomeres is significantly different between human normal and cancer cells. 
However, we don’t yet know if 360A induces less DNA damage in normal cells than in 
cancer cells and/or if the DNA damage response pathway is more efficient in normal cells 
than in cancer cells. In agreement with our preliminary results, RHPS4, which induces 
telomere damage in immortalized fibroblasts, does not induce H2AX phosphorylation in 
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normal fibroblasts (Salvati et al., 2007). This lack of H2AX phosphorylation is not due to 
impairment of DNA damage response pathways because bleomycin and the dominant-
negative form of TRF2 phosphorylate H2AX in normal fibroblasts.  
6. Conclusions 
We showed herein that a specific G-quadruplex ligand, 360A, interacts with the terminal 
ends of human chromosomes in both tumour and normal cells. We find that 360A binds 
preferentially to human chromosome ends in normal and cancer cells but that the G-
quadruplex ligand-induced cell death by apoptosis occurs only in cancer cells. We provide 
evidence that the G-quadruplex ligand provokes telomere deprotection during replication 
and induces telomere aberrations only in cancer cells. Taken together, our results indicate 
that 360A induces telomere instability in cancer cells but not in normal cells. Our results 
thus suggest that the cellular response activated by damaged telomeres and/or mechanisms 
implicated in telomere maintenance are significantly different between human normal and 
cancer cells. We cannot yet exclude the possibility that the protein composition at the 
telomeres and/or organization of the telomeres differ markedly between normal and cancer 
cells, and thereby provide normal cells with a higher degree of telomere stability. 
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